Close Menu

NEW YORK – Roche said today that its Foundation Medicine subsidiary intends to submit an application to the US Food and Drug Administration to get its FoundationOne CDx assay approved as a companion diagnostic for entrectinib (Genentech's Rozlytrek).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.